- Bempedoic acid guidance
- K&M DOAC Monitoring Recommendations for Non-Valvular Atrial Fibrillation (NVAF) in Primary Care.
- NICE guidance for AF
- Lipid Management Pathway
- K&M Anticoagulant position statement and risk mitigation principles
- Dapagliflozin and Empagliflozin in heart failure
- Kent & Medway ICB Position Statement for prescribing Inclisiran
- Preferred
- On Formulary
- Specialist Initiation
- Hospital Use Only
- Unlicensed Medicines